Can we achieve consensus on central venous catheter-related infections?
Central venous catheter-related bacteraemia is a substantial and preventable source of iatrogenic morbidity and mortality. A single episode of catheter-related bacteraemia has an estimated cost of A$50,000, with an attributable mortality between 10 and 35%. Catheter colonization is diagnosed with standard culture techniques. Diagnostic criteria for catheter-related bacteraemia include the results of cultures from the catheter tip, the peripheral blood and other possible sites of infection. The presence of clinical symptoms and subsequent defervescence may assist in making the diagnosis. This review explores the existing definitions of catheter-related infections and proposes a new and more rigorous classification with criteria for definite, probable and possible catheter-related bacteraemia. The authors hope that this classification will enhance the interpretation of the literature and the planning of new investigations. Infection rates can be reduced by appropriate site selection, adequate skin preparation, sterile technique and appropriate dressings. Decreased manipulation of administration sets, with more careful technique and less frequent set replacement, may reduce hub contamination. Infection rates increase with the duration in situ of the catheter, however are not reduced by regular scheduled catheter replacement or guide-wire exchanges. A range of antimicrobial catheter materials and coatings are under investigation, some of which are effective in reducing the rate of catheter-related bacteraemia. Chorhexidine-silver sulphadiazine and rifampicin-minocycline are the best studied combinations to date. Further developments are expected, although none are likely to be as effective as not inserting or removing the central venous catheter when it is not required.
Fraenkel
D J
DJ
Royal Brisbane Hospital, Queensland.
Rickard
C
C
Lipman
J
J
D000890:Anti-Infective Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000145:classification / Q000191:economics / Q000209:etiology / Q000401:mortality / Q000517:prevention & control; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D003428:Cross Infection / Q000145:classification / Q000191:economics / Q000209:etiology / Q000401:mortality / Q000517:prevention & control; D004866:Equipment Contamination / Q000517:prevention & control; D006801:Humans
D000890:Anti-Infective Agents